General Information of Drug Off-Target (DOT) (ID: OT2VE9UU)

DOT Name Calcium release-activated calcium channel protein 1 (ORAI1)
Synonyms Protein orai-1; Transmembrane protein 142A
Gene Name ORAI1
Related Disease
Tubular aggregate myopathy ( )
Combined immunodeficiency due to ORAI1 deficiency ( )
Myopathy, tubular aggregate, 2 ( )
Stormorken syndrome ( )
UniProt ID
CRCM1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2MAK; 4EHQ
Pfam ID
PF07856
Sequence
MHPEPAPPPSRSSPELPPSGGSTTSGSRRSRRRSGDGEPPGAPPPPPSAVTYPDWIGQSY
SEVMSLNEHSMQALSWRKLYLSRAKLKASSRTSALLSGFAMVAMVEVQLDADHDYPPGLL
IAFSACTTVLVAVHLFALMISTCILPNIEAVSNVHNLNSVKESPHERMHRHIELAWAFST
VIGTLLFLAEVVLLCWVKFLPLKKQPGQPRPTSKPPASGAAANVSTSGITPGQAAAIAST
TIMVPFGLIFIVFAVHFYRSLVSHKTDRQFQELNELAEFARLQDQLDHRGDHPLTPGSHY
A
Function
Ca(2+) release-activated Ca(2+) (CRAC) channel subunit which mediates Ca(2+) influx following depletion of intracellular Ca(2+) stores and channel activation by the Ca(2+) sensor, STIM1. CRAC channels are the main pathway for Ca(2+) influx in T-cells and promote the immune response to pathogens by activating the transcription factor NFAT. Plays a prominent role in Ca(2+) influx at the basolateral membrane of mammary epithelial cells independently of the Ca(2+) content of endoplasmic reticulum or Golgi stores. May mediate transepithelial transport of large quantities of Ca(2+) for milk secretion.
Tissue Specificity Expressed in naive CD4 and CD8 T cells (at protein level) . Expressed at similar levels in naive and effector T helper cells .
KEGG Pathway
Calcium sig.ling pathway (hsa04020 )
cAMP sig.ling pathway (hsa04024 )
Platelet activation (hsa04611 )
Renin secretion (hsa04924 )
Aldosterone synthesis and secretion (hsa04925 )
Cortisol synthesis and secretion (hsa04927 )
Cushing syndrome (hsa04934 )
Primary immunodeficiency (hsa05340 )
Reactome Pathway
Ion homeostasis (R-HSA-5578775 )
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers (R-HSA-983695 )
Elevation of cytosolic Ca2+ levels (R-HSA-139853 )

Molecular Interaction Atlas (MIA) of This DOT

4 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Tubular aggregate myopathy DISC11WH Definitive Autosomal dominant [1]
Combined immunodeficiency due to ORAI1 deficiency DISYIUEF Strong Autosomal recessive [2]
Myopathy, tubular aggregate, 2 DIS6RJ7U Strong Autosomal dominant [3]
Stormorken syndrome DIS9US3H Supportive Autosomal dominant [4]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Calcium release-activated calcium channel protein 1 (ORAI1). [5]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Calcium release-activated calcium channel protein 1 (ORAI1). [14]
------------------------------------------------------------------------------------
9 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Calcium release-activated calcium channel protein 1 (ORAI1). [6]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Calcium release-activated calcium channel protein 1 (ORAI1). [7]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Calcium release-activated calcium channel protein 1 (ORAI1). [8]
Estradiol DMUNTE3 Approved Estradiol increases the expression of Calcium release-activated calcium channel protein 1 (ORAI1). [9]
Testosterone DM7HUNW Approved Testosterone decreases the expression of Calcium release-activated calcium channel protein 1 (ORAI1). [10]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Calcium release-activated calcium channel protein 1 (ORAI1). [11]
Demecolcine DMCZQGK Approved Demecolcine decreases the expression of Calcium release-activated calcium channel protein 1 (ORAI1). [12]
Ethanol DMDRQZU Approved Ethanol increases the expression of Calcium release-activated calcium channel protein 1 (ORAI1). [13]
USNIC ACID DMGOURX Investigative USNIC ACID increases the expression of Calcium release-activated calcium channel protein 1 (ORAI1). [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Drug(s)

References

1 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
2 A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature. 2006 May 11;441(7090):179-85. doi: 10.1038/nature04702. Epub 2006 Apr 2.
3 Familial myopathy with tubular aggregates associated with abnormal pupils. Neurology. 2004 Sep 28;63(6):1111-3. doi: 10.1212/01.wnl.0000138575.14424.5f.
4 Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis. Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4197-202. doi: 10.1073/pnas.1312520111. Epub 2014 Mar 3.
5 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
6 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
7 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
8 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
9 17-Estradiol via Orai1 activates calcium mobilization to induce cell proliferation in epithelial ovarian cancer. J Biochem Mol Toxicol. 2020 Dec;34(12):e22603. doi: 10.1002/jbt.22603. Epub 2020 Aug 25.
10 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
11 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
12 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
13 Inhibition of store-operated Ca(2+) channels prevent ethanol-induced intracellular Ca(2+) increase and cell injury in a human hepatoma cell line. Toxicol Lett. 2012 Feb 5;208(3):254-61. doi: 10.1016/j.toxlet.2011.11.007. Epub 2011 Nov 17.
14 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
15 Endoplasmic Reticulum Stress and Store-Operated Calcium Entry Contribute to Usnic Acid-Induced Toxicity in Hepatic Cells. Toxicol Sci. 2015 Jul;146(1):116-26. doi: 10.1093/toxsci/kfv075. Epub 2015 Apr 13.